A Magic Pill for Polishing Glaxo's Public Image?
GlaxoSmithKline is trying to better its reputation in the face of what the Wall Street Journal calls “a series of legal woes that have tarnished the image of Glaxo and other drug makers in recent years.”
To that end, the drug maker decided to suspend U.S. TV ads for anti-impotence pill Levitra. Glaxo told the Wall Street Journal it hasn’t run a TV spot for it since fall 2009.
The article notes that Glaxo and “marketers of other erectile-dysfunction drugs” have seen criticism in the past for running TV commercials with adult themes when children could be watching.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in